Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Amlodipine And Olmesartan Medoxomil In Hypertensive Filipino Patients

This study has been terminated.
(The requirement for Post Marketing Surveillance was lifted by the Philippine FDA)
Information provided by (Responsible Party):
Pfizer Identifier:
First received: August 25, 2010
Last updated: March 17, 2016
Last verified: March 2016
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2014
  Primary Completion Date: January 2014 (Final data collection date for primary outcome measure)